Skip to main content
$0.205 (0%)

High

-

Low

-

Trades

-

Turnover

$0

Volume

0
7 August 2026 at 7:06pm
Register to track RAP and receive email alerts.

Short Interest

ASIC data, 21 Sep 2022

% Shorted

0.03%
vs 0.03% prior report

Most Shorted Rank

573rd
of 712 shorted ASX stocks

Peak Short

0.82%
Jul 2022

Days to Cover

0.4
at 50d avg vol
Subject
RAP Ann: Removal from Official List

RAP Ann: Scheme of Arrangement has been Implemented

RAP Ann: Ceasing to be a substantial holder

RAP Ann: Becoming a substantial holder

RAP Ann: Notification of cessation of securities - RAP

RAP Ann: Ceasing to be a substantial holder

RAP Ann: Suspension from Official Quotation

RAP Ann: Scheme of Arrangement becomes effective

RAP Ann: Scheme of Arrangement - Court Approval

RAP Ann: Becoming a substantial holder

RAP Ann: Results of Scheme Meeting

RAP Ann: Scheme Meeting - Chairman's Address & Presentation

RAP Ann: Becoming a substantial holder

RAP Ann: Appendix 4G

RAP Ann: Corporate Governance Statement

RAP Ann: Appendix 4E and Annual Report

RAP Ann: Dispatch of Second Supplementary Scheme Booklet

RAP Ann: Second Supplementary Scheme Booklet

RAP Ann: Correction to ASX announcement

RAP Ann: Adjournment of Scheme Meeting to a date to be determined

RAP Ann: Best and Final Confirmation and Bridging Loan

RAP Ann: Dispatch of Supplementary Scheme Booklet

RAP Ann: Pfizer raises scheme consideration to A$0.208 per share

RAP Ann: Correction to ASX announcement

RAP Ann: Entry into amended and restated Scheme Implementation Deed

RAP Ann: Investor Conference Call Notification

RAP Ann: Quarterly Activities Report and Appendix 4C

RAP Ann: Quarterly Results and Investor Conference Call Notification

RAP Ann: Study shows efficacy of ResAppDx use with masks

RAP Ann: Dispatch of Scheme Booklet

RAP Ann: Clarification - Scheme Booklet registered with ASIC

RAP Ann: Scheme Update - ACCC condition precedent satisfied

RAP Ann: Scheme Booklet registered with ASIC

RAP Ann: Results of First Court Hearing

RAP Ann: Medgate Licence Agreement Clarification Announcement

RAP Ann: Medgate extends licence agreement and plans to expand use

RAP Ann: ResApp receives FDA 510(k) clearance for SleepCheckRx

RAP Ann: Cough detection patent granted in Australia and Japan

RAP Ann: Scheme Update

RAP Ann: ResApp to present at Gold Coast Investment Showcase

RAP Ann: Results from Data Confirmation Study

RAP Ann: Trading Halt

RAP Ann: Investor Webinar

RAP Ann: Notification of cessation of securities - RAP

RAP Ann: Application for quotation of securities - RAP

RAP Ann: Notification of cessation of securities - RAP

RAP Ann: Reinstatement to Official Quotation

RAP Ann: Increased Scheme Consideration from Pfizer

RAP Ann: Voluntary Suspension Extension

RAP Ann: Voluntary Suspension Extension

Register to track RAP and receive email alerts.

Related Commodities

Name Change
Copper - $6.72
Copper (USD)
-0.06 (0.87%)
7-Aug
Gold - $4,326.60
Gold (USD)
1.40 (-0.03%)
7-Aug
Silver - $62.58
Silver (USD)
-0.25 (0.41%)
7-Aug
Zinc - $3,121.70
Zinc (USD)
-3.60 (0.12%)
7-Aug

Similar Companies

4DX
ALC
CGS
IME
M7T
MDR
PCK
PKS
PME